Research and development expenses, including related party expenses of 399, 259, 465 and 521 for the three and six months ended june 30, 2026 and 2025, respectively
85,337
81,540
82,785
97,836
General and administrative expenses
23,356
18,610
15,589
19,522
Intangible assets impairment loss
41,824
-
-
-
Total operating expenses
150,517
100,150
98,374
117,358
Loss from operations
-148,855
-98,409
-96,445
-115,292
Loss on barloss purchase
-
-
0
-
Interest income
4,948
5,349
3,547
4,594
Other income (expenses), net
-71
7
-33
-54
Total other income (expense), net
4,877
5,356
3,514
4,540
Net income (loss) before income taxes
-143,978
-
-75,809*
-110,752
Income tax benefit
-1,757
-
17,122*
-
Net income (loss)
-142,221
-93,053
-92,931
-110,752
Unrealized loss (gain) on marketable securities, net
-216
-655
-46
212
Total comprehensive income (loss)
-142,437
-93,708
-92,977
-110,540
Basic EPS
-1.11
-0.74
-1.093
-1.06
Diluted EPS
-1.11
-0.74
-1.093
-1.06
Basic Average Shares
127,690,254
125,050,645
85,029,624*
104,109,243
Diluted Average Shares
127,690,254
125,050,645
85,029,624*
104,109,243
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.